Private Healthcare Australia
(PHA) has announced the
appointment of former medical
practitioner and director of
government affairs and policy for
the Johnson & Johnson Family of
Companies in Australia and New
Zealand, Dr Rachel David, to the
ceo role for the organisation.
PHA president Rob Bransby in
making the announcement added,
“This [is] an important period for
the PHI Industry and Dr David’s
extensive career in healthcare
policy, in both Government and the
private sector ensures she is vastly
qualified for this challenging and
rewarding role.”
David is expected to commence in
the role late January 2016.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Dec 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.